1. Novel hypothesis to explain why SGLT2 inhibitors inhibit only 30-50% of filtered glucose load;Abdul-Ghani;Diabetes,2013
2. Therapeutic potential of SGLT2 inhibitors in treating type 2 diabetes mellitus;Amin;Mahidol J. Pharmacol. Sci.,2014
3. Dapagliflozin efficacy and safety: a perspective review;Anderson;Ther. Adv. Drug Saf.,2014
4. Dapagliflozin for the treatment of type 2 diabetes;Anderson;Ann. Pharmacother.,2002
5. Background Document: Dapagliflozin. Endocrinology and Metabolic Drugs Advisory Committee Meeting: July 19, 2011;Anon,2011